These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 7923317
1. Sequential intravenous/oral ciprofloxacin as an empiric antimicrobial therapy: results of a Canadian multicenter study. The Canadian Collaborative Investigational Group. Davis C. Clin Ther; 1994; 16(3):505-21. PubMed ID: 7923317 [Abstract] [Full Text] [Related]
2. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study. Lucasti C, Jasovich A, Umeh O, Jiang J, Kaniga K, Friedland I. Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934 [Abstract] [Full Text] [Related]
3. Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections. Lorian V, Pavletich K. Drugs Exp Clin Res; 1994 May; 20(5):209-14. PubMed ID: 7875058 [Abstract] [Full Text] [Related]
5. Efficacy and safety of oral ciprofloxacin in the treatment of respiratory tract infections associated with chronic hepatitis. Esposito S, Galante D, Bianchi W, Gagliardi R. Am J Med; 1987 Apr 27; 82(4A):211-4. PubMed ID: 3555038 [Abstract] [Full Text] [Related]
6. Ciprofloxacin in severe infections. Aswapokee N, Pruksachatvuthi S, Aswapokee P. J Med Assoc Thai; 1990 Jun 27; 73(6):315-20. PubMed ID: 2230626 [Abstract] [Full Text] [Related]
7. Use of intravenous ciprofloxacin in difficult-to-treat infections. Giamarellou H, Galanakis N. Am J Med; 1987 Apr 27; 82(4A):346-51. PubMed ID: 3555059 [Abstract] [Full Text] [Related]
8. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected]. Iravani A, Tice AD, McCarty J, Sikes DH, Nolen T, Gallis HA, Whalen EP, Tosiello RL, Heyd A, Kowalsky SF. Arch Intern Med; 1995 Mar 13; 155(5):485-94. PubMed ID: 7864704 [Abstract] [Full Text] [Related]
9. A sequential study of intravenous and oral fleroxacin in the treatment of complicated urinary tract infection. Gelfand MS, Simmons BP, Craft RB, Grogan J, Amarshi N. Am J Med; 1993 Mar 22; 94(3A):126S-130S. PubMed ID: 8452168 [Abstract] [Full Text] [Related]
10. Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication. Peloquin CA, Cumbo TJ, Nix DE, Sands MF, Schentag JJ. Arch Intern Med; 1989 Oct 22; 149(10):2269-73. PubMed ID: 2508586 [Abstract] [Full Text] [Related]
11. Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial. Gentry LO, Ramirez-Ronda CH, Rodriguez-Noriega E, Thadepalli H, del Rosal PL, Ramirez C. Arch Intern Med; 1989 Nov 22; 149(11):2579-83. PubMed ID: 2684078 [Abstract] [Full Text] [Related]
12. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy. Wells WG, Woods GL, Jiang Q, Gesser RM. J Antimicrob Chemother; 2004 Jun 22; 53 Suppl 2():ii67-74. PubMed ID: 15150185 [Abstract] [Full Text] [Related]
13. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria. Preheim LC, Cuevas TA, Roccaforte JS, Mellencamp MA, Bittner MJ. Am J Med; 1987 Apr 27; 82(4A):295-300. PubMed ID: 3555051 [Abstract] [Full Text] [Related]
14. [The efficacy and tolerance of Bay-o-9867 (ciprofloxacin) in the treatment of infections of the urinary tract and of the lower respiratory tract]. Quartieri F, Bolognesi S, Sconosciuto F. Recenti Prog Med; 1994 Feb 27; 85(2):96-100. PubMed ID: 8184195 [Abstract] [Full Text] [Related]
15. Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections. Fass RJ. Am J Med; 1987 Apr 27; 82(4A):202-7. PubMed ID: 3555037 [Abstract] [Full Text] [Related]
16. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. Iravani A, Klimberg I, Briefer C, Munera C, Kowalsky SF, Echols RM. J Antimicrob Chemother; 1999 Mar 27; 43 Suppl A():67-75. PubMed ID: 10225575 [Abstract] [Full Text] [Related]
17. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia. Caldwell JW, Singh S, Johnson RH. J Antimicrob Chemother; 1999 Mar 27; 43 Suppl A():129-34. PubMed ID: 10225583 [Abstract] [Full Text] [Related]
18. The role of oral antimicrobials for the management of intra-abdominal infections. Solomkin JS, Dellinger EP, Bohnen JM, Rostein OD. New Horiz; 1998 May 27; 6(2 Suppl):S46-52. PubMed ID: 9654311 [Abstract] [Full Text] [Related]
19. Clinical and economic effect of ciprofloxacin as an alternative to injectable antimicrobial therapy. Powers T, Bingham DH. Am J Hosp Pharm; 1990 Aug 27; 47(8):1781-4. PubMed ID: 2389785 [Abstract] [Full Text] [Related]
20. Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections. Iravani A. Am J Med; 1993 Mar 22; 94(3A):89S-96S. PubMed ID: 8452189 [Abstract] [Full Text] [Related] Page: [Next] [New Search]